NCT07487974

Brief Summary

This study is to assess the impact of sanitary pads infused with active oxygen and negative ions on episiotomy pain, wound healing, and postpartum physical symptoms in primiparous women. Participants will be randomly allocated to either the intervention group, utilizing active oxygen and negative ion pads, or the control group, employing normal postpartum pads. The research will assess pain intensity, recovery advancement, and physical manifestations during the initial postpartum phase. The objective is to ascertain if the intervention offers supplementary advantages relative to usual care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 3, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

March 23, 2026

Completed
9 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 9, 2026

Completed
Last Updated

May 12, 2026

Status Verified

December 1, 2025

Enrollment Period

5 months

First QC Date

December 3, 2025

Last Update Submit

May 10, 2026

Conditions

Keywords

EpisiotomyActive oxygenNegative ionsPainPostpartumprimigravida

Outcome Measures

Primary Outcomes (3)

  • Episiotomy Pain Score

    Episiotomy-related pain will be assessed using a 10-point Visual Analog Scale (VAS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst possible pain.

    Measurements will be conducted at: • 24 hours postpartum • 3rd day postpartum • 7th day postpartum

  • Episiotomy Wound Healing Score

    Wound healing will be evaluated using the REEDA Scale (Redness, Edema, Ecchymosis, Discharge, Approximation). Each item is scored from 0 to 3, with a total score ranging from 0 to 15. Higher scores indicate poorer wound healing (greater tissue trauma).

    Measurement Times: 24 hours after birth 3rd day postpartum 7rd day postpartum

  • Postpartum Physical Symptom Severity

    Postpartum physical symptom severity will be measured using the Postpartum Physical Symptom Severity Scale. The scale consists of 18 items, each rated on a 4-point Likert scale (0 = none, 1 = mild, 2 = moderate, 3 = severe), with total scores ranging from 0 to 54. Higher scores indicate greater severity of postpartum physical symptoms.

    Measurement Times: 24 hours after birth 3rd day postpartum 7rd day postpartum

Study Arms (2)

Pad Group

EXPERIMENTAL

Participants in this group will use sanitary pads containing active oxygen and negative ions during the early postpartum period following episiotomy. All participants will also receive routine postpartum care.

Other: Active Oxygen and Negative Ion Sanitary Pad

Control Group

ACTIVE COMPARATOR

Participants in this group will use standard postpartum sanitary pads during the early postpartum period following episiotomy. All participants will also receive routine postpartum care.

Other: Standard Postpartum Sanitary Pad

Interventions

Participants in the intervention group will use sanitary pads containing active oxygen and negative ions during the early postpartum period following episiotomy. The product is applied as a hygiene pad and is not classified as a drug or medical device. Routine postpartum care will be provided to all participants.

Pad Group

Participants in the control group will use standard postpartum sanitary pads following episiotomy. Routine postpartum care will be provided to all participants. The control product does not contain active oxygen or negative ions.

Control Group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women aged 18 years or older
  • At least primary school education
  • Gestational age between 37 and 42 weeks
  • Single, live, vaginal birth
  • Mediolateral episiotomy performed
  • Hemoglobin level \> 11 mg/dL
  • Voluntary participation and ability to provide informed consent

You may not qualify if:

  • History of high-risk pregnancy
  • History of high-risk or complicated labor
  • Use of operative vaginal delivery methods (forceps, vacuum, etc.)
  • Presence of additional perineal lacerations, including 3rd-degree tears or anal sphincter injury
  • Cephalopelvic disproportion
  • Postpartum hemorrhage
  • Newborn requiring NICU care
  • Diagnosis of vaginal fungal infection or sexually transmitted infections (e.g., herpes simplex, HPV)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eğitim ve Araştırma Hastanesi

Karaman, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain

Interventions

Reactive Oxygen Species

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Free RadicalsInorganic ChemicalsOxygen CompoundsOrganic Chemicals

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The statistician conducting data analysis will be blinded to group assignments. Participants, care providers, and investigators will not be blinded due to the nature of the intervention.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to one of two parallel groups: an intervention group using sanitary pads with active oxygen and negative ions, and a control group using standard postpartum sanitary pads. Both groups will receive routine postpartum care, and outcomes will be compared between groups.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 3, 2025

First Posted

March 23, 2026

Study Start

November 1, 2025

Primary Completion

April 1, 2026

Study Completion

May 9, 2026

Last Updated

May 12, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared due to ethical restrictions, privacy protection regulations, and institutional policies. Only aggregated study results will be reported

Locations